r We have developed a unique prototype to perform brain stimulation in mice. r This system presents a number of advantages and new developments: 1) all stimulation parameters can be adjusted, 2) both positive and negative current pulses can be generated, guaranteeing electrically balanced stimulation regimen, 3) which can be produced with both low and high impedance electrodes, 4) the developed electrodes ensure localized stimulation and 5) can be used to stimulate and/or record brain potential and 6) in vivo recording of electric pulses allows the detection of defective electrodes (wire breakage or short circuits). Abstract Deep brain stimulation (DBS) is used to treat a number of neurological conditions and is currently being tested to intervene in neuropsychiatric conditions. However, a better understanding of how it works would ensure that side effects could be minimized and benefits optimized. We have thus developed a unique device to perform brain stimulation (BS) in mice and to address fundamental issues related to this methodology in the pre-clinical setting. This new microstimulator prototype was specifically designed to allow simultaneous live bioluminescence imaging of the mouse brain, allowing real time assessment of the impact of stimulation on cerebral tissue. We validated the authenticity of this tool in vivo by analysing the expression of toll-like receptor 2 (TLR2), corresponding to the microglial response, in the stimulated brain regions of TLR2-fluc-GFP transgenic mice, which we further corroborated with post-mortem analyses in these animals as well as in human brains of patients who underwent DBS to treat their Parkinson's disease. In the present study, we report on the development of the first BS device that allows for simultaneous live in vivo imaging in mice. This tool opens up a whole new range of possibilities that allow a better understanding of BS and how to optimize its effects through its use in murine models of disease.
Introduction
Deep brain stimulation (DBS) therapy has shown beneficial effects in a number of clinical contexts, including the treatment of Parkinson's disease (PD) (Mehanna & Lai, 2013) , essential tremor (Chopra et al. 2013) , severe dystonia (Amtage et al. 2013; Olaya et al. 2013) , severe obsessive compulsive disorder (Hamani & Temel, 2012; Morishita et al. 2013) , neuropathic pain in spinal cord injury (Previnaire et al. 2009 ), stroke (Owen et al. 2006) , as well as in acute Tourette's syndrome (Ackermans et al. 2011; Rotsides & Mammis, 2013) . Additionally, DBS is currently being tested experimentally in neuropathic pain related to spinal cord injury, stroke, Alzheimer's disease, epilepsy and treatment-resistant depression.
Despite the fact that DBS has already been used clinically and for a number of years, the mechanisms of action remain to be fully understood (Hamani & Temel, 2012) or even identified. This presents an important limitation to the future development of any type of brain stimulation (BS) therapy. In particular, it is essential that we better understand how cells and networks actually respond to BS, and whether this is different for different cell types/regions (Liu et al. 2008; Deniau et al. 2013; Fenoy et al. 2013; Hess et al. 2013) . For this to be realized, it is critical that it can be studied in the laboratory in small animals, which has proven very difficult because of the considerable challenges imposed by the miniaturization of the BS systems while ensuring that they still resemble human devices. In this regard, a number of implantable microstimulation devices have been developed for use in animal models, most of which were designed for large-to medium-size animals, including rats (Table 1) . However, the vast majority of these have shown proof of concept but have not been extensively tested in vivo (Table 1) . Indeed, a single apparatus designed for chronic stimulation has been tested in mice with stimulation reaching a maximum of 10 h (de Haas et al. 2012) . Although mice are the most widely used species in pre-clinical research, especially given the variety of genetic models that exist, their small size has presented an enormous challenge for the successful miniaturization of a BS device (Table 1) . Surgical considerations alone are considerable. They include taking into account parameters such as the volume of the device, which must not interfere with the normal functions of the animal, nor create skin irritation and more important problems requiring full-time care and frequent re-suturing or leading to internal lesions (haemorrhage or excessive pressure on the vertebrae). Postsurgical problems are also non-negligible because the device must be implanted in a such way as to prevent the animal from damaging the system by excessive scratching or by attempting to remove parts of the stimulator.
In the present study, we not only present a new murine BS system, but one that we have designed to exploit concomitant bioluminescence imaging in live animals. Bioluminescence imaging is a non-invasive technology recently developed to observe and quantify different biological processes that can be followed in real time and performed repeatedly in the same animal during extended follow-ups (Sadikot & Blackwell, 2005) . Indeed, this technique has proven especially useful for studying biological phenomena relating to inflammation, axogenesis or neurogenesis in the mouse brain Lalancette-Hebert et al. 2009; Lalancette-Hebert et al. 2011; Cordeau & Kriz, 2008; Hochgrafe & Mandelkow, 2013) . We therefore considered it to be of great interest to study the effects of BS on different brain biological phenomena in vivo using bioluminescence imaging, which has not been possible with any of the small animal BS systems developed thus far (Table 1) .
The physiological, behavioural and therapeutic effects of BS are directly associated with the stimulated/targeted brain region. We chose to do this in the M1 region of the motor cortex because we wanted to ensure that the system could yield the type of data that we needed to move on to more complex types of studies (e.g. stimulation of deeper brain structures, using disease models with combinational behavioural tests). The stimulation of the motor cortex is known to produce beneficial effects in several disease contexts, including chronic pain (Tsubokawa et al. 1991; Nguyen et al. 1999; Nguyen et al. 2000) and PD (Fasano et al. 2008; De Rose et al. 2012; Di Giuda et al. 2012) , in addition to promoting motor recovery after stroke (Katayama et al. 2003; Nouri & Cramer, 2011; Nowak et al. 2012; Takeuchi & Izumi, 2012) . Finally, we were interested to validate our device by comparing/correlating the microglial response obtained with toll-like receptor 2 (TLR2) signaling in mice with respect to post-mortem analyses in both these mice and human brain tissue collected from cases that had received DBS. 
Methods

Biphasic current generator
The design of our microstimulator prototype is based on the development of an external biphasic current generator for which the electronic circuit is illustrated in Fig. 1A . The modulation of the electric pulse frequency and duration is insured through a microprocessor (ATtiny85; Atmel, San Jose, CA, USA), programmed using an Arduino Uno board and its accompanying software (Sparkfun Electronics, Boulder, CO, USA). A voltage reference (1.8 V, ADR318AR5-R2; Analog Devices Inc., Norwood, MA, USA) was used to stabilize the input potential of the microprocessor. The voltage binary pulses generated were converted into positive and negative current pulses within the retroaction loop of an operational amplifier (TLE2022; Texas Instruments, Dallas, TX, USA). To do so, the microprocessor was supplied by a voltage (V MC ) corresponding to half the voltage of the power supply, minus 0.9 V (half the voltage value that was used to feed this microprocessor). The V MC voltage was produced by a resistance (R1), a zener diode (Z) and part A of the operational amplifier (Fig. 1A) . The highest voltage amplitude recorded was 3.62 V, indicative of low electrode impedance, as desired.
Electrodes
In parallel with the microstimulator device, we developed low-impedance electrodes to ensure local brain stimulation (both metal contacts delivering the current are located within the same brain structure). We also opted for bipolar electrodes given that the majority of studies performed in small animals have used the same type of electrodes (Millard & Shepherd, 2007; Baba et al. 2009; Morimoto et al. 2011; de Haas et al. 2012; Perry et al. 2012; Ewing et al. 2013a; Hentall, 2013; Jeffrey et al. 2013; Halpern et al. 2014) . For each electrode, a 23 G disposable injection needle (Fisher Scientific, Whitby, ON, Canada) was carved to create a tube adopting the shape shown in Fig. 2A for a pulsation of 150 μA and ß1.7 nA μm -2 for a pulsation of 120 μA). The steel wire with the stripped end was inserted into the stainless steel tube and fixed with epoxy (#832C-375ML; MG Chemicals, Surrey, BC, Canada). Both wires were welded to a modified miniature neuroconnector (Omnetics, Minneapolis, MN, USA). The end product was a concentric bipolar electrode formed by a stainless steel tube around a stainless steel wire presenting a stripped tip ( Fig. 2A) . As illustrated in Fig. 2B , the electric current was thus produced between the outer stainless tube (outer pole) and the stripped end of the stainless steel wire (inner pole). This approach enabled very localized stimulation, as is performed clinically, since both poles of the electrode were confined within the same region. Furthermore, the metal surface of the tube significantly decreased the impedance of the electrodes, reducing the voltage required to produce the current pulsations. All electrodes were tested in a saline solution before their implantation in vivo. 
Parameters of BS
The effects of stimulation on brain tissue largely depend on electrical parameters (Gustafsson & Jankowska, 1976; Nowak & Bullier, 1998; Garcia et al. 2005) . In the present study, we pre-programmed our biphasic current generator to operate at 130 Hz (Fig. 1B) , a frequency extensively used in the clinic and which has yielded benefits in several conditions, such as pain (Boccard et al. 2014) , dementia (Laxton et al. 2010; Fontaine et al. 2013) , depression Figure 2 . In vivo BS system: from electrode design, implantation and function to impact on animal health A, components of the electrodes. The stereotactic rod serves to hold the electrode in the arm of the stereotactic frame, which allows for its implantation into the brain. Once the electrode is fixed to the skull, this rod is removed. B, schematic cross-section of the mouse brain depicting the implantation site within the primary motor cortex (M1), as well as images of the electrode implantation in a mouse. C, schematic representation of the various constituents of the in vivo BS system. D, recorded in vivo voltage variation induced by the biphasic current. E, weight fluctuation in mice did not exceed 10% and was restricted to the early post-implantation period. There was no significant weight variation detected during the stimulation protocol. Statistical analyses were performed using repeated measures ANOVA (rANOVA) followed by Tukey's post hoc tests. * P < 0.05, * * P < 0.01. e, electrical field; M1, primary motor cortex; STR, striatum. (Rabin & Salvin, 1987; Aouizerate et al. 2004; Jimenez et al. 2005; Mayberg et al. 2005; McNeely et al. 2008; Schlaepfer et al. 2008; Bewernick et al. 2010; Grubert et al. 2011; Kennedy et al. 2011; Puigdemont et al. 2012; Bewernick et al. 2012; Holtzheimer et al. 2012; Lozano et al. 2012; Ramasubbu et al. 2013; Schlaepfer et al. 2013) , epilepsy (Handforth et al. 2006; Boex et al. 2011; Tyrand et al. 2012) , PD (Rizzone et al. 2001; Welter et al. 2004; Sun et al. 2008 ) and essential tremor (Boockvar et al. 2000) . In the motor cortex, specifically, a 130 Hz electric stimulation was shown to modulate cortical excitability (Buffel et al. 2014) .
Because our electrodes are very small (compared to human electrodes), it is critical that the stimulation variables chosen create minimal corrosion and tissue damage. For example, a charge balanced biphasic pulse with delay can initiate action potentials, similarly to the monophasic pulse used in human DBS. However, the charge balanced biphasic pulse with delay does not generate corrosion, where as the monophasic stimulation does. The current intensity, pulse time and interpulse duration were selected in accordance with data reported by Buffel et al. (2014) and Cappaert et al. (2013) . The current amplitude was adjusted a 150 μA per pulsation, corresponding to 50 μA above the threshold (100 μA) necessary to influence excitability of cortical networks (Buffel et al. 2014) . The pulse and interpulse times were pre-programmed at 100 μs based on prior demonstration of the efficacy of this stimulation to induce neuronal/synaptic responses in rat hippocampal slices (Cappaert et al. 2013) .
Animals
TLR2-fluc-GFP transgenic mice (C57BL/6 background) (Lalancette-Hebert et al. 2009; Lalancette-Hebert et al. 2011) were handled in our in-house breeding facility and kept in ventilated cages under standard laboratory conditions (12:12 h dark/light cycle, water and food available ad libitum, weekly cage cleaning). All animal experiments were performed in accordance with the Canadian Guide for the Care and Use of Laboratory Animals, and all procedures were approved by the Institutional Animal Care Committee of Université Laval. In total, 24 males aged 219.9 ± 9.2 days were used in the present study. The number of animals included for each experiment is provided in Table 2 .
Electrode implantation
Mice were anaesthetized with 1-2% isoflurane in oxygen (2 l min −1 ) in an induction chamber. The mouse was placed into a stereotactic frame (model #900 with mouse gas anaesthesia head holder model 923-B and standard accessories; David Kopf Instruments, Tujunga, CA, USA) and body temperature was maintained during the entire period of surgery using a Gaymar T/pump TP-400 heat therapy system (Gaymar Industries Inc., Orchard Park, NY, USA) and pads (TP-3E; Gaymar Industries). The depth of anaesthesia was controlled by monitoring the breathing of the animal (one breath/1-1.5 s, 40-60 breaths min -1 ). The head was shaved and disinfected three times with 70% isopropyl alcohol and 4% chlorhexidine. Lidocaine (0.05%) was S.C. injected at the incision site as a local anaesthetic. Saline (NaCl 0.9%, 1 ml, S.C.) and buprenorphine (0.1 mg kg −1 , I.P.) were injected before and every 12 h for 3 days after surgery for hydration and postoperative analgesia. The skullcap was exposed by a longitudinal skin incision (from nasofrontal to occipital) using a scalpel and small skin clamps. The periosteum was removed by three washes of 3% peroxide and 5% sodium hypochlorite in saline. Two holes were drilled in the skull to introduce the electrodes in the M1 region of the motor cortex. This was based on bregma using the coordinates: anteroposterior, +2.46 mm; mediolateral, ± 1.7 mm; dorsoventral, -0.7 mm; angle 20 deg (Paxinos & Franklin, 2001) (Fig. 2B ). The implanted electrodes and the connector were cemented to the skull using superglue and Ortho-Jet Crystal fast curing orthodontic acrylic resin (Lang Dental, Wheeling, IL, USA). After fixation of the electrodes to the skull, the stereotactic rods were cut and removed (Fig. 2C) . By changing the length of the electrode and adjusting the depth of the rod, the system allows any brain structures to be reached, including deep subcortical structures, such as the subthalamic nucleus.
Semi-chronic BS
During BS, animals were placed in a recording chamber (a plastic circular container of 10 cm in diameter), housed in a quiet room. The electrodes were connected to the biphasic current generator by suspended wires that allowed mice to move freely in the chamber. Each semi-chronic BS session lasted 5 h. Water and food were available ad libitum during the stimulation session. The electrical signals were monitored using a PicoScope 2204 oscilloscope (Pico Technology, Pico Technology, Tyler, TX, USA ). The set-up is illustrated in Fig. 2C .
Monitoring voltage peaks of the current pulse further allowed for the identification of any defective electrodes before and after implantation. The absence of voltage variation during a current pulse suggested a short circuit, whereas the presence of a square pulse of which the amplitude corresponded to the saturation of the system implied a wire breakage. We did not observe any short circuits/wire breakage after the fixation of the electrodes to the skull. When a defective electrode was identified, it was used as a control (non-stimulating electrode). 
Potential measurements within the motor cortex
To measure the brain potential within the M1 region, mice were again anaesthetized in an induction chamber and a face mask was used to maintain anaesthesia during electrical measurements. An oscilloscope (in acquisition mode) was connected to the inner pole extension of both brain electrodes (Fig. 3B) . A clamp coated with a conductive gel was attached to the tail and served as a reference (Fig. 3B) . For data collection, the animal was anaesthetized for less than 2 min and measures were taken prior to stimulation (on days 1 and 9) ( Fig. 3D and F) or 10 min after the stimulation had been stopped (on days 1, 3, 6 and 9) (Fig. 3E) . The cortical potential measured in the present study is equivalent to an EEG, which records the voltage between the tip of the electrode and a reference point; in this case, the tail of the mouse. We quantified the constant voltage rather than the frequency-dependent activity. This measure reflects the electrical influence of all charged elements present in the micro-environment of the electrodes. Constant potential has been shown to respond to pathological or physiological parameters. The induced-electrical change can last from several minutes to hours (Bures et al. 1998) .
General health status of the animals
To monitor the health status of the animals, general observations and weight measurements were performed daily during the postoperative and BS experimental phases. All animals showed normal locomotor activity, as well as the ability to stand on their hind limbs and to feed freely. In addition, none of the animals C, cortical potential after electrode implantation. Statistical analyses were performed using repeated measures ANOVA (rANOVA) followed by Tukey's post hoc tests. * P < 0.05. D, cortical potential within a single 5 h BS session, as recorded on day 1 and day 9 (at the beginning and end of a session). E, cortical potential after a 5 h BS session on days 3, 6 and 9 (compared to baseline). F, cortical potential on day 9 of stimulation (just prior to stimulation session), after an 18 h off stimulation period (compared to baseline). G, voltage amplitude during the postoperative recovery period (H) and during daily BS (I). Voltage amplitude was measured on the first positive current pulse. Statistical analyses were performed using a one-sample t test with a hypothetical value of zero (D-F) or rANOVA followed by Tukey's post hoc tests (H and I). * P < 0.05, * * P < 0.01 and * * * P < 0.001. contra St, electrode contralateral to the stimulating electrode; d, day; nSt, non-stimulating electrode; St, stimulating electrode.
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Bioluminescence imaging
Images were collected using an IVIS R 200 Imaging System (CaliperLS-Xenogen; PerkinElmer, Waltham, MA, USA). Mice received an I.P. injection of D-luciferin (150 mg kg −1 ; CaliperLS-Xenogen; PerkinElmer) 20 min before the imaging session. Animals were deeply anaesthetized before imaging in an induction chamber and the in vivo bioluminescence image acquisition lasted 3 min. A face mask integrated to the IVIS R 200 Imaging System was used to maintain anaesthesia during the imaging session. The signal detected in the region of interest was quantified in terms of the total flux of photons (photons s -1 ). The light intensity was represented as pseudocolor images superimposed over greyscale images of the mouse's head, acquired prior to imaging (Lalancette-Hebert et al. 2009; Drouin-Ouellet et al. 2011) . Animals were imaged at days 1, 3, 6 and 9 days following stimulation. The time points were selected to avoid frequent anaesthesia of the animals but to allow coverage of the entire period of stimulation. From 6 days onwards, the inflammatory response observed plateaued, which further confirmed the time point chosen for sacrifice.
Three-dimensional (3D) reconstruction of bioluminescence imaging
3D reconstruction of photon emission was performed by Living Image software, version 4.0 (PerkinElmer) using imaging tomography algorithms. A 3D reconstruction of the animal was first performed using a structured light imaging approach Lalancette-Hebert et al. 2009 ). The images were produced by a series of parallel laser lines projected onto the mouse. The software allows to analyze the displacement of the laser light to recreate a 3D topography of the animal. Once the 3D surface is created, the software localizes and quantifies the light source within the mouse using three emission filters (600, 620 and 640 nm). Using different wavelengths and considering both the defined emission spectra of the model (in our case, the light generated by luciferin oxidation by genetically modified Firefly luciferase) and the absorbance properties of the different tissues (bones, muscles, brain, etc.), the software localizes the bioluminescent sources and quantifies the amount of emitted photons. Finally, the 3D model of a mouse skeleton is adjusted according to the surface topography to allow for the location of the light signal within the animal. To confirm the localization of the signal, six mice were imaged in a 3D model and observations were consistent across all animals.
Mouse brain extraction and tissue preparation
At the end of the experiment, mice were anaesthetized with a mix of 100 mg of ketamine (Vetalar, Belleville, ON, Canada) and 10 mg of xylazine (Bayer, Etobicoke, ON, Canada) per ml (I.P. injections of 0.1-0.3 ml 10 g -1 ) and perfused transcardially with 50 ml of cold (4°C) phosphate buffered saline (PBS) 1X (BioShop, Burlington, ON, Canada) containing protease inhibitors (Sigma, St Louis, MO, USA) followed by 50 ml of 4% paraformaldehyde in PBS 1X (4°C). The brain was rapidly removed, kept in 4% paraformaldehyde (4°C) for 16 h and stored in sucrose 20% in PBS 1X containing 0.05% sodium azide. 25 μm-thick coronal brain sections were cut using an SM2000 R sliding microtome (Leica, Concord, ON, Canada) and collected in an anti-freeze solution at pH 7.3 containing 0.2 M monophosphate sodium monobasic, 0.2 M monophosphate sodium dibasic, 30% ethylene glycol and 20% glycerol (all Sigma).
Post-mortem analysis on mouse tissue
Immunohistochemistry for the ionized calcium-binding adapter molecule 1 (Iba1) was performed to assess the microglial response. Brain sections were mounted on gelatin-coated slides and blocked for 30 min in 0.1 M PBS containing 0.1% Triton X-100 (Sigma) and 5% normal goat serum (Wisent Bioproducts, Saint-Jean-Baptiste, QC, Canada). Sections were then incubated overnight at 4°C in 1:1000 rabbit anti-Iba1 polyclonal antibody (catalogue number 019-19741; Waco Pure Chemicals Industries, Tokyo, Japan), followed by 1:1500 biotinylated goat anti-rabbit polyclonal antibody (catalogue number BA-1000; Vector Laboratories, Burlington, ON, Canada) for 1 h at room temperature (RT) and subsequently placed in a solution containing an avidin-biotin peroxidase complex (1:400) (ABC Elite kit; Vector Laboratories) for an additional 1 h at RT. The reaction was obtained with a 3,3 -diaminobenzidine tetrahydrochloride (20 mg ml −1 ) solution (Sigma), 12.5% of sodium acetate 1 M, pH 7.2, 26 mg ml −1 nickel sulphate, 5% imidazole 0.2 M, pH 9.2, and 0.01% of 30% hydrogen peroxide (Sigma) at RT. As a negative control, some sections were treated as above, omitting the primary antibody. Sections were finally air-dried, dehydrated in ascending grades of ethanol, cleaned in CitriSolv (Fisher Scientific, Concord, ON, Canada) and coverslipped with DPX mounting media (Electron Microscopy Science, Hatfield, PA, USA). Antibodies and avidin-biotin peroxidase complex were diluted in 0.1 M PBS.
Images were taken with the Simple PCI version 5.0 (Hamamatsu Photonics, Hamamatsu, Japan) software linked to a Nikon eclipse 90i microscope (Nikon Canada Inc., Mississauga, ON, Canada). Images were finalized for illustration using Photoshop and Illustrator CS5 (Adobe Systems, San Jose, CA, USA).
TLR2 autoradiography
The sections were mounted on Superfrost slides (Fisher Scientific Co., Concord, ON, Canada) and air-dried for 1 h. Pre-hybridization was performed in RNase free conditions. A specific [
35 S]UTP-labelled complementary RNA probe (kindly provided by Dr Serge Rivest, Université Laval, Québec, Canada) was used to assess TLR2 mRNA levels. The TLR2 complementary RNA probe stems from 2278 bp (nucleotides 307-2661; GenBank accession #AF185284) and was cloned into a PCR-Blunt II-topo vector. Linearization was made with the EcoRV enzyme. The anti-sense probe was synthesized with [
35 S]UTP and SP6 RNA polymerase. Brain sections were fixed in 4% paraformaldehyde (pH 9.5) at RT for 20 min. Pre-treatment included 0.1 M PBS washes (twice for 5 min), proteinase K 0.1 μg ml −1 for 25 min at 37°C, an acetylation bath (0.25% acetic anhydride, triethanolamine 0.1 M) for 10 min, and then 5 min in standard saline citrate (SSC) (0.3 M NaCl, 30 mM sodium citrate). Successive immersion in ethanol solutions (30%, 60%, and 100% twice; ten dips) was performed for dehydration. In situ hybridization of the riboprobes on tissue sections was performed at 58°C overnight in a standard hybridization buffer [deionized formamide 50%, sodium chloride 5 M, Tris 1 M, EDTA 0.5 M, Denhart's solution 50X, dextran sulphate 50%, tRNA 10 mg ml −1 , dithithreitol (DTT) 1 M, and 35S coupled 2 × 10 6 c.p.m. μl −1 probe]. Post-treatment was performed using successive baths: SSC 4X (30 min), removing coverslips, SSC 4X with DTT 1 M four times (5 min), RNase A 20 μg ml −1 (30 min) at 37°C, SSC 2X with DTT 1 M twice (5 min), SSC 1X with DTT 1 M (5 min), SSC 0.5X with DTT 1 M (10 min) and SSC 0.1X (30 min) at 60°C. Repetitive baths of ethanol solutions (50%, 70%, 95% and 100%; ten dips) were used for further dehydration. Tissue sections were then placed against a BiomaxMR (Kodak, Rochester, NY, USA) radioactive sensitive film. Autoradiograms were developed after exposure for 72 h. Digitized brain images were obtained with a CCD camera model XC-77 (Sony Electronics Inc., New York, NY, USA) equipped with a 60 mm f/2.8D magnification lens (Nikon Canada Inc., Mississauga, ON, Canada).
Post-mortem analysis on human tissue
Human brain paraffin-embedded sections were obtained from the Queen Square Brain Bank (Institute of Neurology, London, UK). Two male PD cases that received subthalamic DBS for 5 and 11 years (age = 69 and 76 years, respectively) were compared with PD cases without DBS (female, 57 years old; male, 69 years old) (for patient demographics, see Table 3 ). Sections were deparafinized in xylene and hydrated using an ethanol gradient. For antigen retrieval, sections were boiled in citrate buffer 0.01 M (pH 6.0) containing 0.05% Tween 20 for 20 min in the microwave. After PBS washes, sections were incubated in a blocking and permeabilizing solution containing 5% donkey normal serum and 0.1% Triton-X-100 in PBS for 60 min at RT. This was followed by an overnight incubation at 4°C in the same solution, containing 1:250 rabbit anti-Iba1 polyclonal antibody (catalogue number 019-19741; Waco Pure Chemicals Industries). Sections were subsequently washed three times in PBS and incubated for 2 h at RT in 1:500 donkey Alexa 488-conjugated anti-rabbit (catalogue number A21206; Invitrogen, Carlsbad, CA, USA) in PBS. After additional washes in PBS, sections were placed in a solution containing 4 ,6-diamidino-2-phenylindole for 30 min at RT and washed again twice with PBS before a 5 min incubation with an autofluorescence eliminator reagent (Millipore, Billerica, MA, USA). Sections were dried and coverslipped using FluorSave reagent (Calbiochem, San Diego, CA, USA). Photomicrographs were taken using a DM6000 B fluorescent light microscope (Leica).
Statistical analysis
Values are expressed as the mean ± SEM. For repeated measures, repeated measure ANOVAs, followed by Tukey's test or Dunnett's post hoc test, were used. When a parameter was measured and compared with a baseline value, a one-sample t test was performed on the variation ( ). The hypothesis was that the studied parameter was different from the baseline if the mean of values was different from zero. Statistical analyses were performed using JMP, version 9 (SAS, Cary, NC, USA) and Prism, version 4.0 (GraphPad Software Inc., La Jolla, CA, USA) and are presented in Table 2 .
For each experimental step, several exclusion criteria were established. For measures of cortical potential, animals presenting with defective electrodes were not used in the final analysis. However, none of the implanted electrodes malfunctioned during the stimulation protocol. For imaging, mice for which the 9 day stimulation protocol was not reached or was interrupted were excluded from analyses. We did not encounter such problems in any of the animals used in the present study. Finally, exclusion criteria were also set for post-mortem analyses. These included significant tissue damage when extracting the brain from the cranial cavity or mice that were not well perfused. In total, three animals were discarded from the analyses based on this criterion. 
Results
Capacities of the developed biphasic current generator
Our prototype allowed us to generate positive and negative pulses (Fig. 1B ) of approximately 150 μA per pulsation. The resistance (R2) (Fig. 1A) determines the amplitude of current pulsation and can be adjusted to produce other current amplitudes in accordance with Ohm's law: current (I) = 1.8 V (voltage pulsation produced by MC)/resistor R2 (Fig. 1A) . The compliance, which corresponds to the range of voltage that can generate the current pulsation, is adjustable using the voltage of the power supply, R1, Z and part A of the operational amplifier (Fig. 1A) .
The maximum compliance calculated was 14.1 V for both positive and negative pulses, which is limited by the maximum voltage input of the voltage reference. The desired regimen of stimulation (number of pulsation per cycle, duration and frequency) can be pre-programmed by the microcontroller (Attiny85). Advantageously, all parameters can be modified during the experimental protocol.
Design of biconcentric electrodes for local stimulation
We chose to develop biconcentric electrodes to insure local stimulation; specifically, stimulation that would be confined to the same brain region, even when targeting very small anatomical structures ( Fig. 2A and B) . Our electrodes are characterized by low impedance, with a recorded voltage peak below 3 V (corresponding to the voltage of a lithium battery) for a 100 μs square pulse of 150 μA amplitude. Our electrode design is simple, easily modelled/assembled and particularly reliable, as only four of 36 electrodes failed after implantation, whereas electrode-related issues were never observed during the experimental protocol (i.e. after surgery).
Real time monitoring of current pulses
Our system was further developed to monitor in real time, using a basic oscilloscope, the voltage response generated within the brain (Fig. 2C ). As shown in Fig. 2D , the potential variation generated by a square current pulse is characterized by a kinetic measure depicting a time constant, indicating that electrodes implanted in the brain act as a resistance-capacitance circuit.
Absence of health-related issues in mice with implantation or BS treatment
The device implantation proved to be safe and well-tolerated. Daily monitoring of all animals used in the present study did not lead to the identification of any signs of behavioural abnormalities, nor convulsions, during or after each BS session. Weight loss recorded after electrode implantation was less than 10% (Fig. 2E) . The weight reduction occurred during the first 5 days after surgery and was quickly followed by weight recovery, confirming that our implantation method did not hinder the ability of mice to eat and/or drink. There was no significant weight variation during the BS treatment period (Fig. 2E ). Of note, neither the surgical, nor the stimulation procedure provoked fatalities, and none of the animals had problems with the cranial fixation of electrodes.
BS modulates motor cortex potential
Using an EEG, we investigated the constant potential within the motor cortex, reflecting the electric status of the micro-environment surrounding the electrodes, during the postoperative and BS periods (Fig. 3A) . This was achieved by measuring the voltage difference between the tip of the electrode and a reference point placed on the tail of the animal (Fig. 3B) . First, we detected a transient increase of potential during the first 2 days after implantation (compared to the day of implantation). The potential stabilized thereafter for the remaining 9 days of the recovery period (Fig. 3C) . The brain's adjustments to stimulation were evaluated by the quantification of the potential before and after a single BS session on the first (day 1) and last days (day 9) of the stimulation protocol. BS significantly increased cortical voltage on the first day of the protocol but not on day 9, revealing an adaptability of the cortex to BS intervention (Fig. 3D) . During the BS protocol, an increase in potential was measurable with the stimulating electrode on days 3, 6 and 9 (Fig. 3E) . The potential did not significantly change with the non-stimulating electrodes (Fig. 3E) . To investigate whether the increase in brain potential was immediate after stimulation or persisted over time, we measured the cortical potential prior to BS on day 9, that is 18 h after the last BS session. The increase in brain potential was still quantifiable with the stimulating electrode at this time point (Fig. 3F) , showing a persistence of the phenomenon.
Consistency of the electrode voltage pulse generated during BS
The voltage peak for the first current pulsation (Fig. 3G ) was used to evaluate the electrical characteristics of the electrode within the brain (properties dependent of the electrode impedance). The voltage significantly increased between day 3 and day 6 after implantation and remained fairly stable (not statistically significant) thereafter (Fig. 3H) . No significant change was observed during the BS protocol (Fig. 3I) , excluding any electrode-related technical problems during the experiment.
Bioluminescence imaging: a window into the mechanisms of action of BS
Using bioluminescence imaging in TLR2-fluc-GFP mice, we quantified the TLR2 signal at different time points after electrode implantation and during the BS protocol (Fig. 4A) . A specific and localized TLR2 signal was observed at the implantation site on days 1 and 3 after surgery ( Fig. 4B and Cb). TLR2 expression significantly decreased on postoperative day 6 and remained stable thereafter ( Fig. 4B and Cb). To ensure the complete stabilization of the TLR2 signal, the stimulation protocol was not initiated before days 12-15 after implantation. A constitutive TLR2 signal was detectable in the olfactory bulb in all conditions, as described previously (Fig. 4B ) (Lalancette-Hebert et al. 2009; Lalancette-Hebert et al. 2011) . During the BS protocol, the TLR2 signal in the stimulated regions increased from 107 × 10 3 ± 15 × 10 3 photons s -1 (baseline) to 277 × 10 3 ± 43 × 10 3 photons s -1 on day 1 and to 523 × 10 3 ± 80 × 10 3 photons s -1 on day 3 (Fig. 4B and Cc). The TLR2 signal subsequently decreased to 223 × 10 3 ± 38 × 10 3 photons s -1 on day 6 and 193 × 10 3 ± 40 × 10 3 photons s -1 on day 9 (Fig. 4B  and Cc) . On the contralateral side, corresponding to the non-stimulating electrode, the level was stable during the 9 day evaluation period, with no significant differences from baseline levels (Fig. 4Cc) .
The 3D reconstruction of TLR2 bioluminescent signals (n = 6 animals imaged) emitted from the brain of electrode-implanted mice confirmed that the signal emerged from deep cortical layers and did not originate from inflammatory responses in superficial tissues as a result of the surgical procedure itself (Fig. 5) .
Microglial responses to electrode implantation in mice and humans
Electrode material and architecture influence the degree of glial response induced after implantation (Ereifej et al. 2011) and can consequently modify the biological and therapeutic effects of DBS (Cicchetti & Barker, 2014) .
To evaluate to what extent the inflammatory response created by our microstimulator resembled that generated by parameters used in the clinic, we looked at histological changes seen with electrode implantation in PD patients compared to that observed in our pre-clinical model. The cavity created by electrode implantation in mice was visible macroscopically (Fig. 6A and B) . In some cases, the demarcation was so clear that we could delineate the exact shape and contours of the electrodes implanted (Fig. 6C) , which we could further be associated to the electric field and histological changes (Fig. 6D) . Further histological evaluation revealed minimal tissue changes around the non-stimulating electrode and conspicuous changes around the stimulating electrode (Fig. 6A, B, D and E). Detection of TLR2 mRNA by autoradiography (Fig. 6B) showed reactivity around the stimulating electrode. The same region also depicted a very localized but slight increase in the density of microglia, with a central region composed of activated cells surrounded by an additional outer boundary of microglia of a similar phenotype (Fig. 6E) . The most noticeable differences were observed in the region between the electrode poles (i.e. in the region of expected maximum electric flow). Histological evaluation of brain samples from patients with PD who had been in receipt of long-term DBS also revealed a mild and localized microglial response, as observed by the presence of amoeboid Iba1+ cells in close vicinity to the electrode tip ( Fig. 6F and G) , similar to that observed in control PD cases who did not receive DBS ( Fig. 6H and I) .
Discussion
Novel prototype allowing live imaging of physiological responses to BS
We report for the first time on a new BS device for use in mice that is compatible with simultaneous bioluminescence imaging, and which allows for the investigation, in vivo, of the impact of BS in small J Physiol 593.10 animals. This new murine BS offers several additional advantages: (1) all stimulation parameters can be adjusted (frequency, pulse duration, number of pulse per cycle, current amplitude); (2) the device can generate positive and negative current pulses, guaranteeing electrically balanced stimulation regimen; (3) the compliance (14.1 V) can yield current pulses in both low and high impedance electrodes; (4) the developed electrodes ensure localized stimulation and (5) can be used to stimulate and/or record brain potential; and (6) in vivo recording of electric pulses allows the detection of defective electrodes (wire breakage or short circuits). In addition to these technical advancements, our microstimulator was designed to adapt to the shape of the mouse, maximally reducing the size (both volume and weight) to avoid discomfort and interference with daily activities of the animal, as well as being inexpensive to build. Finally, the absence of heath-related issues (as testified by significant weight gain after surgery/stimulation), convulsion or abnormal behaviours further supports the safety profile of our device and the minimal trauma created by the electrode implantation.
In recent years, a number of microstimulation devices have been developed for application in rodents (Table 1) . In almost all cases, the implantation of the device would interfere with the bioluminescence scanner (i.e. placed over the mouse's skull) by blocking the detection of emitted light. A couple of models that could, in theory, also potentially allow concomitant imaging are the semi-chronic BS systems developed by Halpern et al. (2014) and Jeffrey et al. (2013) , for which a cranial window was created using cyanoacrylate glue or acrylic resin to anchor the electrodes and the electric pins to the skull (Jeffrey et al. 2013; Halpern et al. 2014) . In their paradigm, the skin was removed over the skull, which constitutes a critical step for allowing successful bioluminescence imaging for two reasons: (1) it prevents light absorbance by the skin and (2) it eliminates the possibility that the bioluminescence signal originates from a superficial or artifact sources (e.g. skin), and not the brain itself and control (implanted without BS) mouse brains. Each row corresponds to images collected in a single mouse (numbers were arbitrarily assigned to compare the same animal on different rows). Mouse #3 did not undergo stimulation and thus illustrates the stability of the TLR2 signal during the postoperative period. Ca method of quantification of the TLR2 bioluminescence signal. The photon emission was measured in two distinct regions (delineated by black circles) corresponding to the areas of implantation of the electrodes. The white arrow points to the constitutive TLR2 signal detected at baseline in the olfactory bulb. Graphs represent the mean ± SEM of the total flux of bioluminescence. During the post-implantation period (Cb) electrodes were compiled separately (left vs. right; n = 12 for 6 mice). The TLR2 signal was most robust on days 1-3 and stable but significantly lower from day 6 to days 12-15. BS generated a significant increase in the TLR2 signal on day 3 (Cb; see also B). TLR2 expression was constant and similar to baseline with the non-stimulating electrode (Cc). Statistical analyses were performed using rANOVA followed by Tukey's post hoc test (Cb) or a Dunnett's post hoc (Cc).
* P < 0.05, * * P < 0.01. bsl, baseline; d, day. (Cordeau & Kriz, 2008) . However, in the BS systems proposed by Halpern et al. (2014) and Jeffrey et al. (2013) , the electrical pins connecting the electrodes to the external stimulator are located directly above them, interposing between the scanner and the brain. To avoid this problem, we replaced the electrical pins by connectors that we placed at the rear of the skull, above the cerebellum (Fig. 2C) , thus placing them away from the site of imaging. In addition, we implanted the electrodes at a 20 deg angle to further limit light interference during imaging. Finally, we tested a number of products and opted for orthodontic acrylic resin to fix the electrodes to the skull because this product was found not to block the light signal emitted within the brain. Indeed, the transparency of this material is ideal for bioluminescence analysis because it does not obstruct the visible light spectrum. Of note, the low impedance of our electrodes is compatible with all chronic stimulation devices reported in the literature (Table 1) , including the small compliance device of de Haas et al. (2012) . In addition, the electric field generated by our electrodes is distributed locally around the electrode, similar to the electric field produced by cylindrical electrode used in clinical settings. Taken together, our device offers a number of advantages over similar tools and also opens new possibilities by which to study the mechanisms of BS. Fig. 4 ) of the TLR2 signal 1 day post-implantation and 8 days after the initiation of the BS protocol. At day 1 post-implantation, two very localized and specific TLR2 signals are visible at the site of the electrode (arrows). The TLR2 signal is also observable within the region of the olfactory bulb (arrowhead), illustrating constitutive baseline TLR2 expression in this region, as described previously (Lalancette-Hebert et al. 2009; Drouin-Ouellet et al. 2011; Lalancette-Hebert et al. 2011) . Similar patterns of expression are observed during the BS protocol, although a single signal is visible given the use of a unilateral stimulation regimen. Again, baseline TLR2 expression in the olfactory bulb is detectable. All coronal, saggital and transaxial planes illustrate the depth of the signal within the cranial vault and therefore clearly indicate that the signal originates from within the brain. Colour scales indicate the source intensity (photons s -1 ).
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Measurements of cortical potential: a tool to detect electric/ionic-dependent changes
When an electrode is inserted into the brain, it comes in contact with an aqueous ionic milieu and therefore with several charged elements, such as cell membranes, blood vessels and extracellular matrices. Consequently, the positively or negatively charged molecules interact with the metal parts of the electrode (according to Helmholtz-Smoluchowski's law) and therefore can trigger a potential, as measured against a reference electrode (Duval et al. 2007) . In the present study, we observed Figure 6 . Post-mortem histological evaluation of the microglial response in mice and humans after BS Immunodetection of the microglial response (Iba1+ cells) using nickel intensified 3,3 -diaminobenzidine tetrahydrochloride (A, C and E), as well as the autoradiographic detection of TLR2 mRNA (B). Arrowheads in (A) and (B) highlight the Iba1+ immunoreactivity and the TLR mRNA signal detected around the stimulating electrode. Arrows indicate the cavity created by the electrodes. Electrodes, drawn schematically (i.e. following an approximate scale), were superimposed on the cavities shown in (A) to further illustrate how it corresponds to the region targeted by the electric current flow (e, curved arrows) generated between the electrode poles (see also Fig. 2B) . D, E, higher magnifications of the Iba1+ immunoreactivity around the electrode cavities, disclosing different patterns of microglial responses with the stimulating (E) and non-stimulating electrode (D). Isolated regions near the non-stimulating electrodes (arrowheads) depict an increased density of microglial cells that have a resting phenotype (day 1). Outside these regions, the tissue appears slightly compressed, although the density of resting microglia is similar to that seen in normal tissue (day 2) or near the electrode implantation site. Histological changes are prominent in the regions of electric flow on the stimulated side (E). This region has diffuse Iba+ staining (between arrowheads), in which there is a concentration of activated microglia (e1). Reactive microglia (e2) are observed at the boundaries of this region, showing that there is a transition between the activated microglia around the electrode and the resting microglia in the unaltered surrounding tissue. F-I, Iba1 immunofluorescence staining (green) revealed a mild microglial response, as observed by the presence of amoeboid Iba1+ cells in close vicinity to the electrode tip (subthalamic nucleus) in PD cases who received long-term DBS (F, G), similar to that observed in PD control cases (H, I). Nuclei are stained with 4 ,6-diamidino-2-phenylindole (blue) in all high magnification images. Scale bars (A-C) = 1 mm; (D, E), = 200 μm; (F) = 100 μm (low magnification image) and 25 μm (high magnification panels). The same scales were used for the remaining panels.
changes in the potential of the motor cortex both in response to electrode implantation and to high-frequency BS treatment. More specifically, the change in cortical potential observed after the first BS session persisted for more than 16 h in the absence of stimulation (after 9 days of a daily 5 h stimulation schedule). At the cellular level, we observed a microglial response around the stimulating electrodes. Although we have not identified the causes for these BS-induced changes, the long-term modulation of BS on the cortical potential could be explained in two ways. First, neuronal activity created by high-frequency BS (Gustafsson & Jankowska, 1976; Nowak & Bullier, 1998; Garcia et al. 2005) can change the excitability of the network, which can further induce a long-term potential, also known as 'spreading depression' (Miettinen et al. 1997; Obeidat et al. 2000; Jarvis et al. 2001) . Second, and as briefly mentioned above, the metal parts of the electrodes act as sensors to detect electrically charged molecules within the brain, including charges associated with cells and the extracellular matrix (Egorova, 1994; Duval et al. 2007) . Consequently, the higher cell density observed around the stimulating electrode could, in part, reflect the long-term potential variation. However, the absence of changes in the electrode impedance suggests that interactions between the metal components of the electrode and the aqueous milieu provided by the cerebral tissue do not strictly dictate the BS-induced variation of potential.
The changes in potential that follow electrode implantation are more difficult to interpret. The variation in electrode impedance suggests that physicochemical parameters, as well as physiological responses, may change after implantation. Consequently, the change in potential could result from a reaction of the non-coated segment of the electrode to the extracellular medium (such as the accumulation of electric charges or ion reaction to the metal), activation of repair mechanisms, inflammation induced by the damage generated by the electrodes or adhesion of charged biological elements surrounding the electrode. However, the temporal correlation between the expression of TLR2 and the instability in the potential of the motor cortex suggests the participation of this toll-like receptor in the regulation of the electric environment around the electrode. On the other hand, both TLR2 expression and cortical voltage are stable 3-6 days after surgery, which suggests a return to baseline or a stabilization of the phenomena responsible for driving this change in potential.
Correlation of the bioluminescence imaging and postmortem inflammatory response in mice and humans
The development of a novel BS system suited to concomitant bioluminescence analysis of the mouse brain allowed us to visualize the effect of BS on TLR2 expression (microglia response) in real time, and will enable the investigation of additional mechanisms using other mouse lines, such as axogenesis or neurogenesis Lalancette-Hebert et al. 2009; Lalancette-Hebert et al. 2011; Cordeau & Kriz, 2008; Hochgrafe & Mandelkow, 2013) . The physical presence of the electrodes induced detectable expression of TLR2 during a brief postoperative period. Thereafter, the presence of electrodes within the brain did not yield detectable expression of TLR2. This transient increase is probably a result of the inflammatory response caused by the tissue damage produced by the introduction of a foreign object within the cerebral tissue. However, we observed a significant increase in TLR2 expression in the first days of BS treatment, with a peak on day 3. This TLR2 expression was specific to BS because there was no expression observed with non-stimulating electrodes. Therefore, the use of a combinatorial imaging-stimulation approach allowed us to identify a transient change in the expression of TLR2/microglial response that could not have been detected by more traditional approaches (ex: post-mortem analysis). This is particularly important given that the long-term repercussions of a transient inflammatory response are not known. It is possible that this brief inflammatory reaction has set in motion a cascade of events that will have long-lasting effects on neuronal circuits (Cicchetti & Barker, 2014) .
The mouse post-mortem histological analysis allowed us to corroborate the imaging data. More specifically, a high density of amoeboid microglia was observed in the area between the poles of the stimulating electrode (i.e. in the region of maximum electric flow). This was not observed with the non-stimulating electrode, confirming that this important microglial activation was caused by the electrical field generated by the stimulation. Interestingly, microglia are known to play a key role in the regulation of functional synapses (Ji et al. 2013) . In a mouse model of excitotoxicity using a TLR2 knockout mouse, microglial activation induced by changes in neuronal activity was shown to be TLR2-dependent (Hong et al. 2010) . The modulatory function of TLR2 on microglial activation was also confirmed in a mouse model of ischaemia (Bohacek et al. 2012) . These results imply the potential implication of TLR2 in the BS-induced microglial activation observed in the present study. Interestingly, both microglial and TLR2 activation are suspected to play a key role in the removal of synapses (Freria et al. 2012; Azevedo et al. 2013) , suggesting the possible synergy of these two factors in remodelling neuronal networks. Finally, additional studies have suggested a role for TLR2 in the recruitment of T cells to the brain, as well as in microglial proliferation (Babcock et al. 2006; Shichita et al. 2012; Wang et al. 2013) , suggesting a relationship between the transient expression of TLR2 and the greater J Physiol 593.10 cell density observed in the region of the electrical fields.
We further compared the microglial response observed in our mice to those seen in the brains of patients with PD in receipt of DBS. In the context of the non-stimulating electrode, we observed a comparable microglial response in mice and humans (i.e. amoeboid morphology of microglial cells and an increase of cell density in the vicinity of the electrode lead). With the stimulating electrodes, the microglial response, at least in terms of cells adopting a reactive phenotype, was more striking, although the duration of the DBS stimulation, which was completely different in mice and humans, prevents the direct comparison of these post-mortem observations.
Conclusions
In summary, we have developed a novel semi-chronic BS device compatible with bioluminescence imaging in mice, offering several advantages over previously reported systems. One major advantage of our system is that all of the characteristics of the device are easily modifiable (frequency, number of pulse per cycle, duration, amplitude) to produce the desired protocol of stimulation, as well as being able to stimulate and record brain potential. Having tested safety, tolerability and stimulation parameters in a normal mouse targeting a brain structure that is easily accessible, the device can now be used in models of diseases combining behavioural measures to study the effects of BS for various conditions. Taken together, we now have developed a tool that can be used to study the effects of BS in mice with all the advantages that this brings.
